Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Lack of the aryl hydrocarbon receptor accelerates aging in mice.

Bravo-Ferrer I, Cuartero MI, Medina V, Ahedo-Quero D, Peña-Martínez C, Pérez-Ruíz A, Fernández-Valle ME, Hernández-Sánchez C, Fernández-Salguero PM, Lizasoain I, Moro MA.

FASEB J. 2019 Nov;33(11):12644-12654. doi: 10.1096/fj.201901333R. Epub 2019 Sep 4.

PMID:
31483997
2.

Role of TLR4 (Toll-Like Receptor 4) in N1/N2 Neutrophil Programming After Stroke.

García-Culebras A, Durán-Laforet V, Peña-Martínez C, Moraga A, Ballesteros I, Cuartero MI, de la Parra J, Palma-Tortosa S, Hidalgo A, Corbí AL, Moro MA, Lizasoain I.

Stroke. 2019 Oct;50(10):2922-2932. doi: 10.1161/STROKEAHA.119.025085. Epub 2019 Aug 27.

PMID:
31451099
3.

Astrocytic p38α MAPK drives NMDA receptor-dependent long-term depression and modulates long-term memory.

Navarrete M, Cuartero MI, Palenzuela R, Draffin JE, Konomi A, Serra I, Colié S, Castaño-Castaño S, Hasan MT, Nebreda ÁR, Esteban JA.

Nat Commun. 2019 Jul 4;10(1):2968. doi: 10.1038/s41467-019-10830-9.

4.

A Neutrophil Timer Coordinates Immune Defense and Vascular Protection.

Adrover JM, Del Fresno C, Crainiciuc G, Cuartero MI, Casanova-Acebes M, Weiss LA, Huerga-Encabo H, Silvestre-Roig C, Rossaint J, Cossío I, Lechuga-Vieco AV, García-Prieto J, Gómez-Parrizas M, Quintana JA, Ballesteros I, Martin-Salamanca S, Aroca-Crevillen A, Chong SZ, Evrard M, Balabanian K, López J, Bidzhekov K, Bachelerie F, Abad-Santos F, Muñoz-Calleja C, Zarbock A, Soehnlein O, Weber C, Ng LG, Lopez-Rodriguez C, Sancho D, Moro MA, Ibáñez B, Hidalgo A.

Immunity. 2019 Feb 19;50(2):390-402.e10. doi: 10.1016/j.immuni.2019.01.002. Epub 2019 Jan 29.

PMID:
30709741
5.

Abolition of aberrant neurogenesis ameliorates cognitive impairment after stroke in mice.

Cuartero MI, de la Parra J, Pérez-Ruiz A, Bravo-Ferrer I, Durán-Laforet V, García-Culebras A, García-Segura JM, Dhaliwal J, Frankland PW, Lizasoain I, Moro MÁ.

J Clin Invest. 2019 Apr 1;129(4):1536-1550. doi: 10.1172/JCI120412. Epub 2019 Feb 25.

6.

AhR Deletion Promotes Aberrant Morphogenesis and Synaptic Activity of Adult-Generated Granule Neurons and Impairs Hippocampus-Dependent Memory.

de la Parra J, Cuartero MI, Pérez-Ruiz A, García-Culebras A, Martín R, Sánchez-Prieto J, García-Segura JM, Lizasoain I, Moro MA.

eNeuro. 2018 Aug 22;5(4). pii: ENEURO.0370-17.2018. doi: 10.1523/ENEURO.0370-17.2018. eCollection 2018 Jul-Aug.

7.

TLR4-Binding DNA Aptamers Show a Protective Effect against Acute Stroke in Animal Models.

Fernández G, Moraga A, Cuartero MI, García-Culebras A, Peña-Martínez C, Pradillo JM, Hernández-Jiménez M, Sacristán S, Ayuso MI, Gonzalo-Gobernado R, Fernández-López D, Martín ME, Moro MA, González VM, Lizasoain I.

Mol Ther. 2018 Aug 1;26(8):2047-2059. doi: 10.1016/j.ymthe.2018.05.019. Epub 2018 Jun 15.

8.

Specific Features of SVZ Neurogenesis After Cortical Ischemia: a Longitudinal Study.

Palma-Tortosa S, García-Culebras A, Moraga A, Hurtado O, Perez-Ruiz A, Durán-Laforet V, Parra J, Cuartero MI, Pradillo JM, Moro MA, Lizasoain I.

Sci Rep. 2017 Nov 27;7(1):16343. doi: 10.1038/s41598-017-16109-7.

9.

Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke.

García-Culebras A, Palma-Tortosa S, Moraga A, García-Yébenes I, Durán-Laforet V, Cuartero MI, de la Parra J, Barrios-Muñoz AL, Díaz-Guzmán J, Pradillo JM, Moro MA, Lizasoain I.

Stroke. 2017 Jun;48(6):1695-1699. doi: 10.1161/STROKEAHA.116.015956. Epub 2017 Apr 20.

PMID:
28428349
10.

Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke.

Bravo-Ferrer I, Cuartero MI, Zarruk JG, Pradillo JM, Hurtado O, Romera VG, Díaz-Alonso J, García-Segura JM, Guzmán M, Lizasoain I, Galve-Roperh I, Moro MA.

Stroke. 2017 Jan;48(1):204-212. doi: 10.1161/STROKEAHA.116.014793. Epub 2016 Nov 29.

PMID:
27899748
11.

Imaging the role of toll-like receptor 4 on cell proliferation and inflammation after cerebral ischemia by positron emission tomography.

Moraga A, Gómez-Vallejo V, Cuartero MI, Szczupak B, San Sebastián E, Markuerkiaga I, Pradillo JM, Higuchi M, Llop J, Moro MÁ, Martín A, Lizasoain I.

J Cereb Blood Flow Metab. 2016 Apr;36(4):702-8. doi: 10.1177/0271678X15627657. Epub 2016 Jan 19.

12.

Rational modulation of the innate immune system for neuroprotection in ischemic stroke.

Amantea D, Micieli G, Tassorelli C, Cuartero MI, Ballesteros I, Certo M, Moro MA, Lizasoain I, Bagetta G.

Front Neurosci. 2015 Apr 29;9:147. doi: 10.3389/fnins.2015.00147. eCollection 2015. Review.

13.

Complexity of the cell-cell interactions in the innate immune response after cerebral ischemia.

Cuartero MI, Ballesteros I, Lizasoain I, Moro MA.

Brain Res. 2015 Oct 14;1623:53-62. doi: 10.1016/j.brainres.2015.04.047. Epub 2015 May 5.

PMID:
25956207
14.

Stereological and flow cytometry characterization of leukocyte subpopulations in models of transient or permanent cerebral ischemia.

Ballesteros I, Cuartero MI, Moraga A, de la Parra J, Lizasoain I, Moro MÁ.

J Vis Exp. 2014 Dec 28;(94). doi: 10.3791/52031.

15.

Neutrophils scan for activated platelets to initiate inflammation.

Sreeramkumar V, Adrover JM, Ballesteros I, Cuartero MI, Rossaint J, Bilbao I, Nácher M, Pitaval C, Radovanovic I, Fukui Y, McEver RP, Filippi MD, Lizasoain I, Ruiz-Cabello J, Zarbock A, Moro MA, Hidalgo A.

Science. 2014 Dec 5;346(6214):1234-8. doi: 10.1126/science.1256478. Epub 2014 Dec 4.

16.

L-kynurenine/aryl hydrocarbon receptor pathway mediates brain damage after experimental stroke.

Cuartero MI, Ballesteros I, de la Parra J, Harkin AL, Abautret-Daly A, Sherwin E, Fernández-Salguero P, Corbí AL, Lizasoain I, Moro MA.

Circulation. 2014 Dec 2;130(23):2040-51. doi: 10.1161/CIRCULATIONAHA.114.011394. Epub 2014 Oct 30.

PMID:
25359166
17.

The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia.

Cuartero MI, de la Parra J, García-Culebras A, Ballesteros I, Lizasoain I, Moro MÁ.

Curr Pharm Des. 2016;22(8):1060-73. Review.

18.

Toll-like receptor 4 modulates cell migration and cortical neurogenesis after focal cerebral ischemia.

Moraga A, Pradillo JM, Cuartero MI, Hernández-Jiménez M, Oses M, Moro MA, Lizasoain I.

FASEB J. 2014 Nov;28(11):4710-8. doi: 10.1096/fj.14-252452. Epub 2014 Jul 25.

PMID:
25063846
19.

Rosiglitazone-induced CD36 up-regulation resolves inflammation by PPARγ and 5-LO-dependent pathways.

Ballesteros I, Cuartero MI, Pradillo JM, de la Parra J, Pérez-Ruiz A, Corbí A, Ricote M, Hamilton JA, Sobrado M, Vivancos J, Nombela F, Lizasoain I, Moro MA.

J Leukoc Biol. 2014 Apr;95(4):587-98. doi: 10.1189/jlb.0613326. Epub 2013 Dec 12.

PMID:
24338629
20.

Smad3 is required for the survival of proliferative intermediate progenitor cells in the dentate gyrus of adult mice.

Tapia-González S, Muñoz MD, Cuartero MI, Sánchez-Capelo A.

Cell Commun Signal. 2013 Dec 13;11:93. doi: 10.1186/1478-811X-11-93.

21.

N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPARγ agonist rosiglitazone.

Cuartero MI, Ballesteros I, Moraga A, Nombela F, Vivancos J, Hamilton JA, Corbí ÁL, Lizasoain I, Moro MA.

Stroke. 2013 Dec;44(12):3498-508. doi: 10.1161/STROKEAHA.113.002470. Epub 2013 Oct 17.

PMID:
24135932
22.

Silent information regulator 1 protects the brain against cerebral ischemic damage.

Hernández-Jiménez M, Hurtado O, Cuartero MI, Ballesteros I, Moraga A, Pradillo JM, McBurney MW, Lizasoain I, Moro MA.

Stroke. 2013 Aug;44(8):2333-7. doi: 10.1161/STROKEAHA.113.001715. Epub 2013 May 30.

PMID:
23723308
23.

Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke.

Hurtado O, Hernández-Jiménez M, Zarruk JG, Cuartero MI, Ballesteros I, Camarero G, Moraga A, Pradillo JM, Moro MA, Lizasoain I.

J Neurochem. 2013 Sep;126(6):819-26. doi: 10.1111/jnc.12269. Epub 2013 May 13.

24.

Daidzein has neuroprotective effects through ligand-binding-independent PPARγ activation.

Hurtado O, Ballesteros I, Cuartero MI, Moraga A, Pradillo JM, Ramírez-Franco J, Bartolomé-Martín D, Pascual D, Torres M, Sánchez-Prieto J, Salom JB, Lizasoain I, Moro MA.

Neurochem Int. 2012 Jul;61(1):119-27. doi: 10.1016/j.neuint.2012.04.007. Epub 2012 Apr 11.

PMID:
22521773
25.

Neurological tests for functional outcome assessment in rodent models of ischaemic stroke.

Zarruk JG, Garcia-Yebenes I, Romera VG, Ballesteros I, Moraga A, Cuartero MI, Hurtado O, Sobrado M, Pradillo JM, Fernandez-Lopez D, Serena J, Castillo-Melendez M, Moro MA, Lizasoain I.

Rev Neurol. 2011 Nov 16;53(10):607-18. English, Spanish.

26.

Dopamine and α-synuclein dysfunction in Smad3 null mice.

Tapia-González S, Giráldez-Pérez RM, Cuartero MI, Casarejos MJ, Mena MÁ, Wang XF, Sánchez-Capelo A.

Mol Neurodegener. 2011 Oct 13;6:72. doi: 10.1186/1750-1326-6-72.

Supplemental Content

Loading ...
Support Center